Moran, Leuthardt awarded LEAP funding

The LEAP Gap Fund is open to any person or team with potential or existing WashU intellectual property. Through the program, teams receive mentorship from experts in their fields and work with the Skandalaris Center team and partners to create clear development and commercialization plans to ready their projects.

Six teams were selected for funding to ready their projects for commercialization, including the Moran/Leuthardt project, “SYMPEL: a Simple Neuromodulation Solution to Address Complicated Diseases”, a patent-pending, platform neuromodulation electrode system designed to be easily placed in a minimally invasive manner near the sympathetic chain located on the sides of the spine.

Reflecting on his project’s funding win, Dr. Eric Leuthardt shared, “I’m excited to have received the LEAP award. This provides critical funding for an extremely innovative and platform technology that will revolutionize how we think about treating chronic disease. These types of high-risk/high reward projects are not possible without the initial investment from LEAP, which is critical in paving the path towards the future.”

Read more at the Skandalaris Center website.